OVERVIEW: Gilead’s grantmaking revolves around HIV/AIDS, liver disease, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.
IP TAKE: Grantseekers should be aware that Gilead’s review process can take up to 12 weeks. So this isn’t a funder for those looking for fast funding.
PROFILE: The philanthropic arm of the biopharmaceutical Gilead Sciences centers its grantmaking on organizations in the “core therapeutic areas” of HIV/AIDS, liver disease, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions.
The overall focus of Gilead’s grantmaking is projects that improve the health of local communities within its therapeutic areas of interest.
Much of Gilead Foundation grantmaking strives to increase treatment capacity, improve access to treatment, increase patient knowledge, and further educate healthcare providers on disease identification, diagnosis, and treatment. In the HIV space, the foundation also awards grants to develop simplified treatments, cure research, and pre-exposure prophylaxis programs.
Some of the bigger nonprofits receive grants of $250,000 and up, but most grants tend to stay within $50,000 to $250,000. For-profit organizations are also eligible for support, though they must apply through Gilead’s Independent Medical Education Department, rather than the foundation.
To learn more about Gilead’s grants, check out its Giving Highlights page.
Gilead accepts grant applications year-round through its website. The foundation recommends that potential grantees submit applications at least six weeks prior to the start of their projects.
- Howard Jaffe, President
- Meredith Hahn, Vice President, Corporate Social Responsibility